Company Applies to Legally Manufacture Heroin and Meth
Published Date: 7/23/2026
Notice
Summary
American Radiolabeled Chem wants to become a big-time maker of some powerful controlled substances, including drugs like heroin and methamphetamine. People and companies affected can share their thoughts or ask for a hearing by September 21, 2026. This move could impact drug manufacturing rules and involves careful government review, but no direct costs are mentioned yet.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-18200, Stephen Bossenberry, M.D.; Decision and Order
2026-17592, Thomas Earley, D.D.S.; Decision and Order
Dr. Thomas Earley from Ohio lost his DEA registration because he no longer has permission to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA canceled his registration by default. This means he can’t legally prescribe or manage controlled drugs anymore, effective immediately.
2026-17594, Atlantic Treatment Center, LLC; Decision and Order
The DEA has officially shut down Atlantic Treatment Center in Florida because it lost its state license and federal certification to treat substance use disorders. This means the center can no longer operate legally, protecting public health and safety. The center’s DEA registration expired on June 30, 2026, and this decision finalizes the revocation, making it clear no more services can be offered.
2026-17589, Leila Kump, M.D.; Decision and Order
Previous / Next Documents
Previous: 2026-14914, Privacy Act of 1974; System of Records; Correction
The Department of Defense fixed a mistake about when a privacy record system change takes effect. Instead of August 17, 2026, the correct date is July 16, 2026. This update affects anyone tracking these privacy rules and makes sure the timeline is clear—no extra costs or delays involved!
Next: 2026-14916, Information Collection: NRC Form 313, Application for Materials License and NRC Forms 313A (Radiation Safety Officer (RSO)), 313A (AMP), 313A (Authorized Nuclear Pharmacist (ANP)), 313A (Authorized User Training, Experience and Preceptor Attestation (AUD)), 313A (Authorized User Training, Experience, and Preceptor Attestation (AUT)), and 313A (Authorized User Training, Experience and Preceptor Attestation (AUS))
The Nuclear Regulatory Commission is renewing its forms for people and businesses applying for materials licenses and radiation safety roles. If you work with radioactive materials or oversee safety, this affects you! The NRC wants your feedback by August 24, 2026, but there’s no new cost or big changes—just keeping things up to date and clear.